Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioVie Inc

7.14
-0.4300-5.68%
Post-market: 6.60-0.5400-7.56%19:57 EDT
Volume:67.51K
Turnover:491.95K
Market Cap:13.24M
PE:-0.43
High:7.46
Open:7.45
Low:7.07
Close:7.57
Loading ...

BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference

GlobeNewswire
·
09 Jul

BioVie Inc. Unveils Presentation on Transformative Therapies for Alzheimer's, Parkinson's, and Ascites

Reuters
·
08 Jul

BioVie Inc. trading halted, news pending

TIPRANKS
·
04 Jul

BioVie Inc - Approves 1-for-10 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
28 Jun

BioVie Inc. Announces 1-for-10 Reverse Stock Split Effective July 7, 2025

Reuters
·
28 Jun

BioVie announces poster on patient-centric accessibility of SUNRISE-PD trial

TIPRANKS
·
26 Jun

BioVie Inc. Conducted Special Stockholders Meeting

Reuters
·
25 Jun

BioVie Enrolls First Patient in Address-Lc Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated With Long Covid

THOMSON REUTERS
·
15 May

Press Release: BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth

Dow Jones
·
05 May

New to The Street Airs on Bloomberg TV Saturday, April 26 at 6:30 PM ET Featuring BioVie (NASDAQ: BIVI), Skip Barber Racing School with CFO Michael Berg, CommercialVille.tv, Sustainable Green Team (OTCPK: SGTM) WaterLess Garden, and The Business of Blockchain with Michael Casey

ACCESS Newswire
·
26 Apr

BRIEF-Biovie Initiates Sunrise-Pd Clinical Trial Assessing Bezisterim In Early Parkinson’S Disease With First Patient Enrolled

Reuters
·
16 Apr

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

GlobeNewswire
·
16 Apr

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming

ACCESS Newswire
·
12 Apr

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

ACCESS Newswire
·
29 Mar

BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025

GlobeNewswire
·
27 Mar

New to The Street's FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese's The Big Skinny on eXoZymes, and Banzai CEO Joe Davy

ACCESS Newswire
·
25 Mar

New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)

ACCESS Newswire
·
10 Mar

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

ACCESS Newswire
·
04 Mar

New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM)

ACCESS Newswire
·
23 Feb

Is BioVie (NASDAQ:BIVI) In A Good Position To Invest In Growth?

Simply Wall St.
·
13 Feb